Early research (Phase 1)Study completedNCT00005835What this trial is testingN99-02: Melphalan and Buthionine SulfoximineWho this might be right forNeuroblastoma New Approaches to Neuroblastoma Therapy Consortium 31
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Early research (Phase 1)Study completedNCT02765243What this trial is testingAnti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent NeuroblastomaWho this might be right forNeuroblastomaEffects of Immunotherapy Zhujiang Hospital 12
Early research (Phase 1)Study completedNCT00036959What this trial is testingABT-751 in Treating Young Patients With Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Study completedNCT00004078What this trial is testingIrinotecan in Treating Children With Refractory Solid TumorsWho this might be right forChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more Children's Oncology Group 181
Testing effectiveness (Phase 2)UnknownNCT00392340What this trial is testingTopotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 NeuroblastomaWho this might be right forNeuroblastoma Children's Cancer and Leukaemia Group 63
Large-scale testing (Phase 3)Study completedNCT01156142What this trial is testingDoxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyWho this might be right forHead and Neck CancerMucositisOral Complications of Radiation Therapy+1 more Alliance for Clinical Trials in Oncology 155
Early research (Phase 1)Ended earlyNCT00053950What this trial is testingPyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk NeuroblastomaWho this might be right forDisseminated NeuroblastomaRecurrent Neuroblastoma National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Early research (Phase 1)Study completedNCT00002748What this trial is testingGene Therapy in Treating Children With Refractory or Recurrent NeuroblastomaWho this might be right forNeuroblastoma St. Jude Children's Research Hospital 38
Early research (Phase 1)Study completedNCT00005978What this trial is testingN99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With NeuroblastomaWho this might be right forNeuroblastoma New Approaches to Neuroblastoma Therapy Consortium
Early research (Phase 1)Study completedNCT01048892What this trial is testingSeneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesWho this might be right forAdrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more Children's Oncology Group 22
Early research (Phase 1)Ended earlyNCT02163356What this trial is testingFenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant NeuroblastomaWho this might be right forRecurrent NeuroblastomaNeuroblastoma South Plains Oncology Consortium 4
Early research (Phase 1)Study completedNCT00101270What this trial is testingOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)WithdrawnNCT01174537What this trial is testingNew Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and NeuroblastomaWho this might be right forGlioblastomaSarcomaNeuroblastoma Hadassah Medical Organization
Testing effectiveness (Phase 2)Study completedNCT00040872What this trial is testingMultiple Therapies in Treating Patients With Advanced NeuroblastomaWho this might be right forNeuroblastoma Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Active Not RecruitingNCT01711554What this trial is testingLenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent NeuroblastomaWho this might be right forRecurrent NeuroblastomaRefractory Neuroblastoma National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Study completedNCT00006102What this trial is testingRebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphomaNeuroblastoma+3 more National Cancer Institute (NCI) 200
Testing effectiveness (Phase 2)Study completedNCT00793351What this trial is testingReduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous TransplantationWho this might be right forNeuroblastoma Samsung Medical Center 25
Early research (Phase 1)Study completedNCT00295919What this trial is testingN2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent NeuroblastomaWho this might be right forNeuroblastoma Children's Hospital Los Angeles 80